For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Vaccine makers will have to run large new trials before updated shots can be approved for everyone who is not at a higher-than-average risk.

Pediatricians should provide teens with their contraceptive of choice on the same day as counseling, in the absence of medical contraindications.